Page last updated: 2024-08-24

tetraiodothyroacetic acid and losartan potassium

tetraiodothyroacetic acid has been researched along with losartan potassium in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Duh, EJ; Gong, J; Wei, Y; Xu, Z; Yoshida, T	1

Other Studies

1 other study(ies) available for tetraiodothyroacetic acid and losartan potassium

Article	Year
Inhibition of pathological retinal angiogenesis by the integrin αvβ3 antagonist tetraiodothyroacetic acid (tetrac). Experimental eye research, 2012, Volume: 94, Issue:1 Topics: Angiogenesis Inhibitors; Animals; Blotting, Western; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Disease Models, Animal; Endothelium, Vascular; Erythropoietin; Humans; Integrin alphaVbeta3; Intravitreal Injections; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Oxygen; Phosphorylation; Retinal Neovascularization; Thyroxine; Vascular Endothelial Growth Factor A	2012

Article

Year

Inhibition of pathological retinal angiogenesis by the integrin αvβ3 antagonist tetraiodothyroacetic acid (tetrac).

Experimental eye research, 2012, Volume: 94, Issue:1

Topics: Angiogenesis Inhibitors; Animals; Blotting, Western; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Disease Models, Animal; Endothelium, Vascular; Erythropoietin; Humans; Integrin alphaVbeta3; Intravitreal Injections; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Oxygen; Phosphorylation; Retinal Neovascularization; Thyroxine; Vascular Endothelial Growth Factor A

2012